spirofuropyridine alpha-7 neuronal nicotinic receptor agonists (AstraZeneca)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namespirofuropyridine alpha-7 neuronal nicotinic receptor agonists (AstraZeneca)
Drug Alias Namespirofuropyridien alpha-7 nicotinic ACh receptor agonists (AstraZenenca)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor protein alpha-7 subunit modulators
TargetsNeuronal acetylcholine receptor protein alpha-7 subunit
Therapy Area/IndicationsCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsCognition Disorders

Other Information

ATC CodeN/A
Related LinksN/A